1335 related articles for article (PubMed ID: 26433488)
1. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
2. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
Singh VK; Saini A; Chandra R
Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
[TBL] [Abstract][Full Text] [Related]
3. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
4. The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.
Jain H; Dhawan P; Rao S; Lalwani N; Shand H
Anticancer Agents Med Chem; 2023; 23(4):368-382. PubMed ID: 36056850
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
7. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
Li L; Ni R; Zheng D; Chen L
Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
[TBL] [Abstract][Full Text] [Related]
8. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
9. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
10. Delivering cancer stem cell therapies - a role for nanomedicines?
Schätzlein AG
Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine-mediated drug targeting of cancer stem cells.
Singh D; Minz AP; Sahoo SK
Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells and drug resistance: the potential of nanomedicine.
Vinogradov S; Wei X
Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
[TBL] [Abstract][Full Text] [Related]
17. EpCAM-Antibody-Labeled Noncytotoxic Polymer Vesicles for Cancer Stem Cells-Targeted Delivery of Anticancer Drug and siRNA.
Chen J; Liu Q; Xiao J; Du J
Biomacromolecules; 2015 Jun; 16(6):1695-705. PubMed ID: 25988863
[TBL] [Abstract][Full Text] [Related]
18. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
19. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
Chen K; Huang YH; Chen JL
Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
[TBL] [Abstract][Full Text] [Related]
20. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]